Lv5
1130 积分 2024-08-09 加入
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
1天前
待确认
Discovery of de novo peptides by mRNA and RaPID displays with post-translational modification methods
1天前
待确认
Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates
1天前
待确认
Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy
23天前
已完结
Nanobodies unlock new mechanisms to target G protein-coupled receptors
23天前
已关闭
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
29天前
已完结
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
29天前
已关闭
Bispecific Antibodies in B-Cell Lymphomas: Mechanisms, Efficacy, Toxicity, and Management
29天前
已完结
When will we have a clone? An industry perspective on the typical CLD timeline
1个月前
已完结
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies
4个月前
已完结
皖公网安备34019202002308
